Publications
110
Citations
1,950
Est. group size
~8
Recurring co-author estimate
Active years
26
Publishing since 2001
Sarah Khan's work centers on breast cancer treatment and clinical trials, including studies of targeted drugs and hormone therapies for HER2-negative and hormone receptor-positive advanced breast cancer. The publication record also includes work on cancer care delivery, health equity in clinical trial enrollment, and supportive care topics such as sleep disturbance during chemotherapy, alongside occasional publications in unrelated clinical areas.
Publication output grew from single digits in 2017-2018 to a peak of 20 in 2024, though 2025-2026 counts appear sharply lower, possibly reflecting incomplete recent data.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER2−/PIK3CA Wild-Type Advanced Breast Cancer
Journal of Clinical Oncology · 2026
- 350P Precision oncology insights: Mapping germline BRCA testing protocols for PARP inhibitor intervention in HER2 negative advanced breast cancer
ESMO Open · 2025
- Abstract P5-09-24: Neoadjuvant (NA) immunotherapy (IO) combined with chemotherapy in triple negative breast cancer (TNBC): A UK real world experience from three centres
Clinical Cancer Research · 2025
- Abstract P4-11-21: The use of adjuvant Abemaciclib in HR+, HER2- early breast cancer: a multi-institutional UK experience
Clinical Cancer Research · 2025
- Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
Journal of Clinical Oncology · 2024
- Are We the Problem? A Call to Action for Addressing Institutional Challenges to Engaging Community Partners in Research
International Journal of Environmental Research and Public Health · 2024
- Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study
Supportive Care in Cancer · 2024
- Menstruation-Related Angina—The Wee Hours
International Journal of Angiology · 2024
- Niraparib Maintenance Therapy for Brain Metastasis in Ovarian Endometrioid Adenocarcinoma With Peritoneal Carcinomatosis: A Comprehensive Case Study and Literature Review
Cureus · 2024
- Medical applications of additive manufacturing
Elsevier eBooks · 2024
- Abstract 1000: Clinician and clinical trial staff perspectives on factors that impact enrollment of Black women in breast cancer trials
Cancer Research · 2024
- Abstract A090: Gender Disparities in the National Institutes of Health Funding for Breast Oncology
Cancer Research · 2024
- Abstract 1301: Comparing VA and safety-net hospital patient-reported care metrics and provider recommendations to address social determinants of health and demographics
Cancer Research · 2024
- Impact of a care delivery intervention for patients with socioeconomic disadvantages, in their preferred language of English or Spanish.
Journal of Clinical Oncology · 2024
- LDCT lung cancer screening implementation in a Veterans Affairs hospital: A quality initiative.
Journal of Clinical Oncology · 2024
- Journal of Clinical Oncology×7
- Cancer Research×5
- Cureus×4
- Figshare×4
- Pakistan Journal of Medical and Health Sciences×3
- Robert Wesolowski
Medicine · The Ohio State University
- Gilbert Bader
Medicine · The Ohio State University
- Margaret E. Gatti‐Mays
Medicine · The Ohio State University
- Patrick Schnell
Medicine · The Ohio State University
- Preeti Sudheendra
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile